1. Catalog
  2. 2025 AES Digital Select
2025 AES Digital Select
(34)
Availability
On-Demand
34 Courses
Expires on Mar 17, 2026
Cost
Member: $675.00
Non-Member: $1,275.00
Credit Offered
47 CME Credits
  • 2025 AES Digital Select
  • 2025 ePoster gallery
  • Continuing Education for Nurses and Pharmacists
  • AES Annual Meeting/Digital Select Session Types
  • Planner and Faculty Disclosures
  • Recommended


Statement of Need
The need for this activity has been determined based on identifying professional practice gaps, previous course evaluations, and AES self-assessments. The educational content of this activity was based upon current issues and topics provided by the Annual Meeting Committee and membership. 

Target Audience
Neurologists, epileptologists, pediatric neurologists, nurses, psychologists, neuropsychologists, nurse practitioners, physician assistants, pharmacists, researchers, and scientists. 

Global Learning Objectives
This comprehensive educational meeting provides learners with opportunities to: 

  1. Increase knowledge about the diagnosis and treatment, including novel diagnostic methods and therapeutic modalities of, various manifestations of epilepsy and common comorbidities to enhance clinical practice and improve patient outcomes. 

  1. Be informed about the latest research developments in epilepsy that may translate into clinical care and human therapy in the near future. 

  1. Consider the public health implications of epilepsy and the impact of the disease on patients, communities, and health systems. 

NOTE: Each session has its own specific learning objectives available for review on AES Learn.

Mission Statement
The American Epilepsy Society (AES) promotes research and education for physicians and other healthcare professionals dedicated to the prevention, treatment, and cure of epilepsy. Its continuing professional education (CPE) offers an array of activities to assist the learner in assessing their educational needs and expanding their knowledge, competence and performance in the field of epilepsy, which leads to an improvement in the outcomes of care. 

The CPE program always reinforces the fundamental components of epilepsy care in accordance with an Epilepsy Core Curriculum, including quality improvement and patient safety. In addition, its educational interventions also provide an opportunity to advance professional practice in new and emerging areas of the specialty. In recognition of the importance of the added qualification in epilepsy by the American Board of Psychiatry and Neurology as well as the Maintenance of Certification requirements, AES is committed to the provision of educational opportunities and tools that aid in the certification and MOC requirements. 

 The expected results of AES s program of continuing professional development are as follows: 

  • AES's CPE Program fosters a culture of interprofessional collaboration amongst the cadre of professionals that care for persons with epilepsy. 

  • AES's CPE Program enhances the professional practice of healthcare professionals who care for persons with epilepsy. 

  • The AES's CPE Program provides education in epilepsy therapy to increase the competence of clinicians in the use of these complex and multi-layered options to manage epilepsy in patients. 

  • The AES's CPE Program uses educational interventions as a tool to improve the quality of care and patient safety of persons with epilepsy. 

Accreditation
This enduring activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education. The American Epilepsy Society (AES) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

AMA PRA Category 1 Credit  Designation
The American Epilepsy Society designates this enduring activity for a maximum of 47.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

International Credits
The American Medical Association has determined that non-U.S. licensed physicians who participate in this CME activity are eligible for AMA PRA Category 1 Credits. 

Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credits from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 47.0 hours of Category 1 credit for completing this program. 

Maintenance of Certification
The American Board of Psychiatry and Neurology accepts AMA PRA Category 1 CME Credits. The CME credits earned from the AES 2025 Annual Meeting may be applied toward your ABPN CME requirement. 

Disclosure Policy and Resolution of Conflicts of Interest
It is the policy of the American Epilepsy Society to ensure balance, independence, objectivity, and scientific rigor. All individuals involved in the selection, development, and presentation of content are required to disclose any real or apparent conflicts of interest. Conflicts of interest will be resolved by AES prior to an educational activity being delivered to learners. In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, AES requires that any person who is in a position to control content of a CME activity must disclose all relevant financial relationships that they have with an ineligible company. AES has implemented the mechanisms of prospective peer review of this CME activity to identify and resolve any conflicts. Additionally, the content of this activity is based on the best available evidence. 

Unapproved Use Disclosure
The American Epilepsy Society requires CME authors to disclose to learners when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved) and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information. Information about pharmaceutical agents/devices that is outside of U.S. Food and Drug Administration approved labeling may be contained in this activity. 

Disclaimer
This CME activity is for educational purposes only and does not constitute the opinion or endorsement of, or promotion by, the American Epilepsy Society. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label, investigational, and/or experimental uses. 

To view the ePoster gallery and poster author list visit:AES 2025 ePoster Gallery

How to Get Your Certificate 
1. Go to aes.cmecertificateonline.com 
2. Click on the 2025 AES Annual Meeting – Enduring Content link. 
3. Evaluate the meeting. 
4. Print, download, or save your certificate for your records. 
5. If you lose your certificate, or need help, go to help.cmecertificateonline.com 

Joint Accreditation Statement Text Box 2, Textbox
In support of improving patient care, this activity is planned and implemented by Amedco and the American Epilepsy Society. Amedco is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. 

Professions in scope for this activity are listed below. 

Amedco Joint Accreditation Provider Number: 4008163 

Pharmacists & Pharmacy Technicians 
Amedco LLC designates this activity for a maximum of 37.50 knowledge-based CPE contact hours. 

UAN JA4008163-9999-25-253-H01-P | UAN JA4008163-9999-25-253-H01-T 

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior. 

Nurses 
Amedco LLC designates this activity for a maximum of 42.50 ANCC contact hours. 

Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity. 

Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity. 

Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement. 

 
Objectives - After Attending This Program You Should Be Able To

1. Increase knowledge about the diagnosis and treatment, including novel diagnostic methods and therapeutic modalities of, various manifestations of epilepsy and common comorbidities to enhance clinical practice and improve patient outcomes.
2. Be informed about the latest research developments in epilepsy that may translate into clinical care and human therapy in the near future.
3. Consider the public health implications of epilepsy and the impact of the disease on patients, communities, and health systems. 

Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5) 

All individuals in a position to control the content of CE are listed HERE. (Link PDF of Disclosure list) 

 

The AES Annual Meeting/Digital Select offers relevant, high-quality educational programming across diverse work settings, professional roles, and experience levels. Whether you are just starting with the specialty, have a limited background in epilepsy, or are highly fluent with complex topics, you will find sessions and content relevant to your needs. 

Session Types 

Annual Course: Encourages in-depth exploration of important topics related to epilepsy, focused on clinical care, including review of the science underlying the topics, reviews of clinical research, and discussion of the associated clinical implications. The Annual Course includes a mixture of educational lectures, clinical vignettes, and panel discussions. 

Basic Science Skills Workshops: Deliver learning opportunities on basic science research techniques and methodologies. Attendees will learn about approaches and applications they can incorporate into their own research. Included in meeting registration fee. 

Clinical Skills Workshops: Deliver hands-on and interactive learning opportunities in focused clinical areas. Attendance at each workshop is limited to a small number of participants to allow optimal interaction. Advance registration and an additional fee are required. 

Dialogues to Transform Epilepsy: This session introduces transformative neurobiological research from outside the epilepsy field, with discussions on how those advances could accelerate progress in epilepsy. 

Epilepsy Fellowship Program Directors Meeting: Provides a forum for current clinical epilepsy program directors, clinical neurophysiology program directors, and those interested in starting an ACGME Fellowship, to address challenges in running a program and meeting accreditation requirements. This session will meet ACGME program requirement II.A.4. 

Epilepsy Surgery Skills Workshop: Epilepsy surgeons discuss and illustrate different surgical techniques and approaches related to epilepsy surgery followed by hands-on practice at teaching stations. Topics include temporal lobe surgeries, extra-temporal resections, invasive monitoring methods, and hemispheric surgeries. 

Epilepsy Exchange: Recognize the accomplishments of distinguished leaders in clinical epilepsy and research and/or highlight current developments in the field. 

Investigators Workshops (IW): Highlight exciting developments in basic, translational, and clinical epilepsy research in a format promoting interactive discussion. Speakers include established and junior epilepsy investigators, as well as researchers from other fields. 

Poster Sessions: Posters are grouped by general topic category at various times throughout the meeting. Poster authors are available for discussion during each session. Check the program for author present times. In addition, the following special poster sessions offer additional times to interact with authors 

Basic Science Poster Session: This session features the most exciting and innovative studies focused on understanding the basic mechanisms of epilepsy and using cutting-edge approaches to understand and treat the mechanisms of epilepsy. 

Broadening Representation Inclusion and Diversity by Growing Equity (BRIDGE): This session spotlights research relating to the needs of underserved populations along with showcasing the work of accomplished investigators who identify with groups historically under-represented in medicine and research. 

Pediatric Epilepsy Highlight Session: This session showcases scientific abstracts focused on topics in clinical care and research in pediatric epilepsy. 

Platform Sessions: Three concurrent sessions highlighting selected key scientific abstracts consisting of author presentations followed by Q&A. 

Poster Walking Tours: Tours of selected posters led by leading experts in topic areas. 

Professional Development: Offers mentorship, training, and information geared to early career professionals or anyone considering a career change. 

Special Interest Groups (SIG): Offer information and networking for attendees with similar interests, in sessions organized by AES members. Although the sizes of SIG sessions vary, all lend themselves to active participation and dialogue. 

Symposia: Provide the major educational activities at the Annual Meeting. Topics range from clinically oriented presentations reviewing common issues in epilepsy to more complex topics combining basic sciences and clinical neurology. While target audiences differ, all symposia include discussion of clinically relevant information. 

Planning Committee Member and Speaker Disclosures of Financial Relationship

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, the AES requires that any person who is in a position to control content of a CME activity must disclose all relevant financial relationships that they have with an ineligible company.

All relevant financial relationships with ineligible companies have been mitigated.

Planning Committee Member and Speaker Disclosures of Financial Relationships

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, the AES requires that any person who is in a position to control content of a CME activity must disclose all relevant financial relationships that they have with an ineligible company. All relevant financial relationships with ineligible companies have been mitigated.

The following Planning Committee Members have indicated that they have no financial relationships to disclose. (* Indicates also a Speaker, ^ indicates also a Content Reviewer):

JoLynn Amsden

Shivani Bhatnagar

Carrin Brandt

Dana Bridges

Nitish Chourasia

Catherine Christian-Hinman*

Lisa Clifford

Laura Ewell

Andres Fernandez

Alica Goldman*

Howard Goodkin*

Phil Jackson

Rebekah Kaska

Meghann Kelly*

Lee David Klemens

Candi LaSarge

Lynn Liu

Abigail Lofchie

Heather McKee*

Kimberly Ndahayo

Katherine Noe

Joel Oster

Scott Pearson

Ghazala Perven

Nicole Ralston

Amanda Riisen

Paige Romanello

Patricia Rogers

Lindsay Schommer

Elaine Seto

Hae Won Shin

Yinchen Song*

Shawna Strickland

Sarah Tefft

Ignacio Valencia*

The following Planning Committee Members have disclosed financial relationships ( * Indicates also a Speaker, ^ indicates also a Content Reviewer):

Ahmed Abdelmoity* - Speaker's Bureau: LivaNova USA, Inc.

Jon Cokley - Consultant - UCB Biosciences, Inc., Azurity Pharmaceuticals, Inc., Wolters Klewer Health, Inc.

Erin Fecske - Consultant - Voluntis; Grant / Contract - Health Resources and Services Administration

Jorge Gonzalez-Martinez* - Consultant: DIXI

Janet Greenwood - Neuropace - Stock

Dana Harrar - Intellectual Property  - Other Intellectual Property - UpToDate, Inc., Springer Publishing Company

Shahram Izadyar^ - Grant: Xenon Pharmaceuticals; Neurona Therapeutics (PI, grant handled by institution)

Sarah Kelley - Consultant - Elsevier

John Schreiber - Consultant - Denali Therapeutics, Stoke Therapeutics, UCB, Neurocrine Biosciences, Inc., Longboard Pharmacueticals, Longboard Pharmacueticals

David Spencer* - Consultant: Neuropace, Inc., Jazz Pharmaceuticals, Inc.; Research Grant - Neurona; Royalties - Oxford Press

Ana Suller Marti* - Consultant: Jazz Pharmaceuticals, Paladin Laboratories

Bethany Thomas* - Consultant: Jazz Pharmaceuticals, Neurelis, Xenon Pharmaceuticals, SK LifeScience; Speakers Bureau: LivaNova USA, Inc., SK LifeScience

Speaker Disclosures of Financial Relationships

The following Speakers have indicated that they have no financial relationships to disclose (^ indicates also a Content Reviewer):

Andreas Alexopoulos

Edilberto Amorim

Syed Anwar

David Auerbach

Maysaa Basha

Stephanie Baulac

Fiona Baumer

Tracy Bedrosian

Anne Berg

Adriana Bermeo-Ovalle

Cady Block

Juan Bottan

Tanya Brown

Maria Jose Bruzzone Giraldez

Esther Bui

Jeffrey Calhoun

Sydney Cash

Lei Chen

Denise Chen

Moufawad El Achkar Christelle

Eisha Christian

Robin Cook

Craig Coopersmith

J. Helen Cross

Arthur Cukiert

Arianna Damiani

Louis Dang

Rohit Das

Benjamin Deneen

Jason Ding

Elizabeth Donner

Jenny Downs

Behnaz Esmaeili

Aria Fallah

Olga Farole

Daniel Freedman

Jacqueline French

Naiara Garcia Losarcos

Nina Garga

Jennifer Gelinas

Luciana Giambarberi

Edward Glasscock

Ezequiel Gleichgerrcht

Teneille Gofton

Christina Gross

Christa Habela^

Cecil Hahn

Erin Heinzen

Chloe Hill

Kimberly Houck

Wen-han Hu

Lara Jehi

Frances Jensen

Nathalie Jette

Andres Jimenez Gomez

Barbara Jobst

Monika Jones

Jaideep Kapur

Megan Keeler

Marissa Kellogg

Emily Klatte

Dennis Lal

Alain Zingraff Lekoubou Looti

Yi Li

Christos Lisgaras

Anli Liu

Judy Liu

Dana LoTempio

Emma Macdonald-Laurs

Rama Maganti

Eric Marsh

Kathryn McClain

Carrie McDonald

Mauricio Medina

Sonia Mejia

Nishant Mishra

Quynh Anh Nguyen

Adam Ostendorf

Bruce Ovbiagele

Nicholas Poolos

Sara Preisendanz

Ramya Raghupathi

Shilpa Reddy

Erafat Rehim

Anny Reyes

Andrea Rossetti

Clio Rubinos

Justin Ryan

Dragos Sabau

Priyanka Sabharwal

Jessica Sabino

Daniel San Juan Orta

Sarah Schmitt^

Eric Segal

Arjune Sen

Leigh Sepeta

Zubeda Sheikth

Nishant Sinha

Lacey Smith

Ivan Soltesz

Mirja Steinbrenner

Kelly Sweeney-Widman

Juan Toro Perez

Manjari Tripathi

Stephen VanHaerents

Annamaria Vezzani

Jorge Vidaurre

Paula Voinescu

Konrad Wagstyl

Genna Waldman

Nora Wong

Michael Wong

Sukhvir Wright

Ifrah Zawar

Julie Ziobro

Quratulain Zulfiqar Ali

Deepti Zutshi

The following Speakers have disclosed financial relationships (^ Indicates also Content Reviewer):

Nicholas Abend - Consultant: Demos, Ceribell, Inc.

Amza Ali - Consultant: F. Hoffman-LaRoche AG, GlaxoSmithKline

Elizabeth Berry-Kravis - Consultant: Biogen, F. Hoffman LaRoche, Jaguar, Novartis, Ultagenyx Pharmaceuticals; Grant: Biomarin Pharmaceuticals, F. Hoffman LaRoche, Ionis, Jaguar, Neurogene, Orphazyme, Shionogi Inc, Taysha, Ultragenyx Pharmaceutical Inc., Zynerba

Angela Birnbaum - Grant: UCB, Vireo Health, Green Goods

Rebecca Bromley - Contsultant: UCB

Jordan Cole - Speaker: Illumina, Inc.

Divyanshu Dubey - Consultant: Argenx, UCB

Colin Ellis - Consultant: EpiMinder

Krista Eschbach - Consulant: Medtronic, Inc., Neurocrine Biosciences, Inc., UCB Biosciences, Inc.

Anteneh Feyissa - Consultant: Neurelis, Inc.

Elizabeth Gerard - Consulatant: Stoke Therapeutics; PI Clinical Trials: Eisai, Pharmaceuticals, Inc

Saadi Ghatan - Consultant: NeuroPae

Nicholas Gregg - Grant: Medtronic

Nitish Harid - Consulatant: Xenon Pharmaceuticals, Inc

Sonia Hernandez-Diaz - Consultant: F. Hoffman LaRoche, Moderna; Grant: Takeda, UCB

Khalil Husari - Grant: SK Life Science, Inc.

Emily Johnson - Consultant: EpiWatch

Kristina Julich - Consultant: Zevra Therapeutics, Cyclotherapeutics, Clinical Outcomes Solutions

Ioannis Karakis - Consultant: Ceribell, Inc., Epitel, GlaxoSmithKline, UCB

David King-Stephens - Consultant: Neurelis, Inc., Eisai, Inc, SK Life Science, Inc, UCB, Inc, NeuroPace, Inc.

Kathryn Lalor - Consultant: Eysz; Clinincal Trial: UCB Biosciences, Inc.

Samden Lhatoo - Consultant: LivaNova, NeuroPace, Inc.

Kimford Meador - Grant: Medtronic Navigation Inc, Eisai, Inc.

Heather Mefford - Consultant: SYNGAP Research Fund

Avani Modi - Consultant: UCB

Carrie Muh - Consultant: Monteris Medical Corporation, LivaNova USA, Inc.

Caroline Neuray - Consultant: Saniona, Clouds of Care

Leisha Osburn - Owner: Next Gen Neuro, LLC

Josef Parvizi - Consultant: Ceribell

Mark Richardson - Consultant: NeuroPace, Inc.

Andres Rodriguez - Consultant: SK Life Science, Inc.

Clio Rubinos - Consultant: Azurity Pharmaceuticals, Inc.

Lam Sandi - Consultant: Brainlab, Inc., Encoded Therapeutics, Ovid Therapeutics, Synergia, LivaNova USA, Inc.

Tristan Sands - Consultant: Biohaven Pharmaceuticals, Inc., BioMarin Pharmaceutical

Ingrid Scheffer - Contractor: Anavex Life Sciences, ES-Therapeutics, Cereval Therapeutics, Praxis Precision Medicines, EpiMinder Inc, Epygenyx, Neuren Pharmaceuticals,  Cerecin Inc, Xenon Pharmaceuticals, Zogenix Inc., Ultragenyx Pharmaceutical Inc., Encoded Therapeutics,

Shobi Sivathamboo - Grant: Jazz Pharmaceuticals

Derek Southwell - PI: Neurona Therapeutics

Torbjorn Tomson - Grant: Angelini, Zentiva, Bial, Teva Pharmaceutical Industries, Eisai, GlaxoSmithKlein, Glenmark Pharmaceutical Industries, Accord Pharma, UCB SA, Ecu Pharma, GW Pharma, SF Group, Sanofi

Content Reviewer of Financial Relationships

The following Content Reviewers have indicated that they have no financial relationships to disclose:

Timothy Ainger

Hai Chen

Kelly Coulehan

Jessica Falco-Walter

David Ficker

Tatyana Gitlevich

Adam Greenblatt

Leona Gunasekera

Abeer Hani

David Harris

Jacqueline Hirschey

Jennifer Jaskiewicz

Erica Johnson

Sucheta Joshi

Prakash Kotagal

Andre Lagrange

Casandra Mateo

Prasad Policherla

Simona Proteasa

Neggy Rismanchi

Matt Rowan

Thitiwan Simasathien

Laveena Singla

Maria Stefanidou

Fahd Sultan

Thirukan Swaminathan

Ashley Thomas

Daniel Weber

The following Content Reviewer has disclosed financial relationships:

Tyler Gaston - Consultant: Xenon Pharmeceuticals, Neurelis, Inc.

 

Powered By